{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T22:01:40Z","timestamp":1764540100549},"reference-count":63,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.3892\/mmr.2013.1525","type":"journal-article","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T11:59:40Z","timestamp":1371211180000},"page":"451-455","source":"Crossref","is-referenced-by-count":34,"title":["Serotonin and serotonin transporter in the rectum of patients with irritable bowel disease"],"prefix":"10.3892","volume":"8","author":[{"given":"MAGDY","family":"EL-SALHY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"INGVILD","family":"WENDELBO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DORIS","family":"GUNDERSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,6,14]]},"reference":[{"key":"key20180108013726_b1-mmr-08-02-0451","first-page":"17","article-title":"A world view of IBS","volume-title":"Irritable Bowel Syndrome","author":"Thompson","year":"2002"},{"key":"key20180108013726_b2-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","article-title":"U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact","volume":"38","author":"Drossman","year":"1993","journal-title":"Dig Dis Sci"},{"key":"key20180108013726_b3-mmr-08-02-0451","volume-title":"Irritable Bowel Syndrome: Diagnosis, Pathogenesis and Treatment Options","author":"El-Salhy","year":"2012"},{"key":"key20180108013726_b4-mmr-08-02-0451","first-page":"pii0410","article-title":"Irritable bowel syndrome","volume":"2012","author":"Ford","year":"2012","journal-title":"Clin Evid (Online)"},{"key":"key20180108013726_b5-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cgh.2012.02.029","article-title":"Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis","volume":"10","author":"Lovell","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180108013726_b6-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2036.2006.02989.x","article-title":"Prevalence and management of abdominal cramping and pain: a multinational survey","volume":"24","author":"Quigley","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108013726_b7-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/00365520500442542","article-title":"Prevalence, comorbidity and impact of irritable bowel syndrome in Norway","volume":"41","author":"Vandvik","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"key20180108013726_b8-mmr-08-02-0451","first-page":"1910","article-title":"The epidemiology of irritable bowel syndrome in North America: a systematic review","volume":"97","author":"Saito","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"key20180108013726_b9-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/BF02071408","article-title":"Impact of irritable bowel syndrome on quality of life","volume":"41","author":"Whitehead","year":"1996","journal-title":"Dig Dis Sci"},{"key":"key20180108013726_b10-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","article-title":"Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time","volume":"109","author":"Agreus","year":"1995","journal-title":"Gastroenterology"},{"key":"key20180108013726_b11-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0016-5085(80)90142-0","article-title":"Functional bowel disorders in apparently healthy people","volume":"79","author":"Thompson","year":"1980","journal-title":"Gastroenterology"},{"key":"key20180108013726_b12-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gut.43.6.770","article-title":"Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population","volume":"43","author":"Kennedy","year":"1998","journal-title":"Gut"},{"key":"key20180108013726_b13-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(95)90738-6","article-title":"Medical costs in community subjects with irritable bowel syndrome","volume":"109","author":"Talley","year":"1995","journal-title":"Gastroenterology"},{"key":"key20180108013726_b14-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","article-title":"The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects","volume":"17","author":"Hungin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108013726_b15-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmj.304.6819.87","article-title":"Irritable bowel syndrome in the general population","volume":"304","author":"Jones","year":"1992","journal-title":"BMJ"},{"key":"key20180108013726_b16-mmr-08-02-0451","first-page":"451","article-title":"Functional disorders of the colon","volume":"58","author":"Bordie","year":"1972","journal-title":"J Indian Med Assoc"},{"key":"key20180108013726_b17-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"M184","DOI":"10.1093\/gerona\/50A.4.M184","article-title":"Bowel disorders impair functional status and quality of life in the elderly: a population-based study","volume":"50","author":"O\u2019Keefe","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key20180108013726_b18-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0016-5085(91)90275-P","article-title":"Irritable bowel syndrome in office-based practice in the United States","volume":"100","author":"Everhart","year":"1991","journal-title":"Gastroenterology"},{"key":"key20180108013726_b19-mmr-08-02-0451","first-page":"495","article-title":"Prevalence of irritable bowel syndrome: a community survey","volume":"54","author":"Wilson","year":"2004","journal-title":"Br J Gen Pract"},{"key":"key20180108013726_b20-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(83)91802-0","article-title":"Organic and functional disorders in 2000 gastroenterology outpatients","volume":"1","author":"Harvey","year":"1983","journal-title":"Lancet"},{"key":"key20180108013726_b21-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11894-009-0039-x","article-title":"The burden of IBS: looking at metrics","volume":"11","author":"Spiegel","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"key20180108013726_b22-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"key20180108013726_b23-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1443-9573.2006.00265.x","article-title":"Rome III: the new criteria","volume":"7","author":"Drossman","year":"2006","journal-title":"Chin J Dig Dis"},{"key":"key20180108013726_b24-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(87)90304-7","article-title":"Prognosis in the irritable bowel syndrome: a 5-year prospective study","volume":"1","author":"Harvey","year":"1987","journal-title":"Lancet"},{"key":"key20180108013726_b25-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/bjc.2011.65","article-title":"Irritable bowel syndrome and risk of colorectal cancer: a Danish nationwide cohort study","volume":"104","author":"Norgaard","year":"2011","journal-title":"Br J Cancer"},{"key":"key20180108013726_b26-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3109\/00365528809090204","article-title":"Chronic non-organic upper abdominal pain: diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5- to 7-year follow-up study","volume":"23","author":"Sloth","year":"1988","journal-title":"Scand J Gastroenterol"},{"key":"key20180108013726_b27-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/00365520310004524","article-title":"Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life","volume":"38","author":"Pace","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"key20180108013726_b28-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/gast.2000.16484","article-title":"The impact of irritable bowel syndrome on health-related quality of life","volume":"119","author":"Gralnek","year":"2000","journal-title":"Gastroenterology"},{"key":"key20180108013726_b29-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/MCG.0b013e318189a7f9","article-title":"International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit","volume":"43","author":"Drossman","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"key20180108013726_b30-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler","year":"2002","journal-title":"Gastroenterology"},{"key":"key20180108013726_b31-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2982.2006.00792.x","article-title":"Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse","volume":"18","author":"Coates","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"key20180108013726_b32-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.3748\/wjg.v13.45.6041","article-title":"Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome","volume":"13","author":"Wang","year":"2007","journal-title":"World J Gastroenterol"},{"key":"key20180108013726_b33-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3349\/ymj.2010.51.1.45","article-title":"Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection - an observation in a small case control study","volume":"51","author":"Kim","year":"2010","journal-title":"Yonsei Med J"},{"key":"key20180108013726_b34-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1440-1746.2008.05574.x","article-title":"The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors","volume":"23","author":"Lee","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108013726_b35-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2982.2006.00771.x","article-title":"Enteroendocrine cell counts correlate with visceral hypersensitivity in patients with diarrhoea-predominant irritable bowel syndrome","volume":"18","author":"Park","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"key20180108013726_b36-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","article-title":"Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS","volume":"125","author":"Dunlop","year":"2003","journal-title":"Gastroenterology"},{"key":"key20180108013726_b37-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.47.6.804","article-title":"Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome","volume":"47","author":"Spiller","year":"2000","journal-title":"Gut"},{"key":"key20180108013726_b38-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.3109\/00365521.2010.503965","article-title":"Chromogranin A as a possible tool in the diagnosis of irritable bowel syndrome","volume":"45","author":"El-Salhy","year":"2010","journal-title":"Scand J Gastroenterol"},{"key":"key20180108013726_b39-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/mmr.2012.1087","article-title":"Chromogranin A cell density in the rectum of patients with irritable bowel syndrome","volume":"6","author":"El-Salhy","year":"2012","journal-title":"Mol Med Rep"},{"key":"key20180108013726_b40-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3892\/ijmm_00000183","article-title":"Ghrelin in patients with irritable bowel syndrome","volume":"23","author":"El-Salhy","year":"2009","journal-title":"Int J Mol Med"},{"key":"key20180108013726_b41-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2010.04251.x","article-title":"Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia","volume":"31","author":"Dizdar","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108013726_b42-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1007\/s10620-010-1169-6","article-title":"Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome","volume":"55","author":"El-Salhy","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key20180108013726_b43-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s10620-011-1948-8","article-title":"Low densities of serotonin and peptide YY cells in the colon of patients with irritable bowel syndrome","volume":"57","author":"El-Salhy","year":"2012","journal-title":"Dig Dis Sci"},{"key":"key20180108013726_b44-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/03009739709178939","article-title":"Image analysis of the duodenal endocrine cells in mice with special reference to optic densitomertry","volume":"102","author":"El-Salhy","year":"1997","journal-title":"Ups J Med Sci"},{"key":"key20180108013726_b45-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","article-title":"Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome","volume":"126","author":"Coates","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180108013726_b46-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2006.02858.x","article-title":"Review article: intestinal serotonin signalling in irritable bowel syndrome","volume":"23","author":"Mawe","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108013726_b47-mmr-08-02-0451","first-page":"74","article-title":"Occurrence and distribution of 5-hydroxytryptamine (enteramine) in the living organism","volume":"9","author":"Erspamer","year":"1957","journal-title":"Z Vitam Horm Fermentforsch"},{"key":"key20180108013726_b48-mmr-08-02-0451","first-page":"G433","article-title":"Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception","volume":"275","author":"Chen","year":"1998","journal-title":"Am J Physiol"},{"key":"key20180108013726_b49-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"258","DOI":"10.5056\/jnm.2012.18.3.258","article-title":"An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome","volume":"18","author":"Spiller","year":"2012","journal-title":"J Neurogastroenterol Motil"},{"key":"key20180108013726_b50-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1113\/jphysiol.2008.156984","article-title":"Afferent hypersensitivity in a mouse model of post-inflammatory gut dysfunction: role of altered serotonin metabolism","volume":"586","author":"Keating","year":"2008","journal-title":"J Physiol"},{"key":"key20180108013726_b51-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2006.04.017","article-title":"Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease","volume":"4","author":"Coleman","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180108013726_b52-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1523\/JNEUROSCI.16-07-02352.1996","article-title":"Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract","volume":"16","author":"Wade","year":"1996","journal-title":"J Neurosc"},{"key":"key20180108013726_b53-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.21-16-06348.2001","article-title":"Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"key20180108013726_b54-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.gastro.2010.03.032","article-title":"Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients","volume":"139","author":"Faure","year":"2010","journal-title":"Gastroenterology"},{"key":"key20180108013726_b55-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/gut.2003.030882","article-title":"Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders","volume":"53","author":"Kim","year":"2004","journal-title":"Gut"},{"key":"key20180108013726_b56-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2006.11.020","article-title":"Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome","volume":"132","author":"Camilleri","year":"2007","journal-title":"Gastroenterology"},{"key":"key20180108013726_b57-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"G219","DOI":"10.1152\/ajpgi.90202.2008","article-title":"Candidate genes and sensory functions in health and irritable bowel syndrome","volume":"295","author":"Camilleri","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20180108013726_b58-mmr-08-02-0451","first-page":"31","article-title":"Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls","volume":"21","author":"Kumar","year":"2012","journal-title":"J Gastrointestin Liver Dis"},{"key":"key20180108013726_b59-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1365-2982.2006.00829.x","article-title":"Serotonin transporter gene polymorphism and irritable bowel syndrome","volume":"18","author":"Park","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"key20180108013726_b60-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2982.2007.00905.x","article-title":"A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome","volume":"19","author":"Saito","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"key20180108013726_b61-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.molmed.2008.05.001","article-title":"The genetics of the serotonin transporter and irritable bowel syndrome","volume":"14","author":"Colucci","year":"2008","journal-title":"Trends in molecular medicine"},{"key":"key20180108013726_b62-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"e54831","DOI":"10.1371\/journal.pone.0054831","article-title":"Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome","volume":"8","author":"Colucci","year":"2013","journal-title":"PloS One"},{"key":"key20180108013726_b63-mmr-08-02-0451","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2982.2005.00745.x","article-title":"Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review","volume":"18","author":"Park","year":"2006","journal-title":"Neurogastroenterol Motil"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2013.1525\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T11:22:25Z","timestamp":1715512945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2013.1525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,14]]},"references-count":63,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,6,14]]},"published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.3892\/mmr.2013.1525"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2013.1525","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,14]]}}}